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ABSTRACT: Escherichia coli are known pathogenic organism that has caused diseases which has led to severe 
morbidity and increased death rate. The occurrence of extended spectrum beta Lactamase (bla) producing Escherichia 
coli has been on the rise. Water samples were investigated as a potential reservoir for the Extended Spectrum Beta-
Lactamase (ESBL) - producing E. coli using phenotypic (culture-based) and molecular methods. Double disc synergy 
test was determined between a disc of amoxicillin-clavulanate (20µg/10µg) (augmentin) and a 30-µg disc of each third-
generation cephalosporin antibiotic placed at a distance of 20 mm from centre to centre on a Mueller-Hinton Agar  
plate streaked with the  isolate. An isolate was considered to be ESBL negative if there was no enhancement between 
any of the cephalosporin and the clavulanate-containing discs and were then subjected to specific Polymerase Chain 
Reaction (PCR). Eighty-four environmental E. coli was isolated. 58(69.04%) showed positivity for ESBL production. 
E. coli isolates positive for ESBL-production selected and subjected to plasmid curing were all plasmid mediated. 16 
isolates subjected to PCR to identify the presence of blaSHV (Sulphydryl Variable), blaTEM (Temoneira) and 
blaCTX-M (Cefotaximase) genes revealed that 11(68.7%) of these had at least one ESBL gene (either blaCTX-M or 
blaTEM, or both), 5(31.3%) isolates do not have any of the three ESBL genes, and blaSHV was not detected in any of 
the isolates. The results of this study indicate the widespread prevalence of ESBLs in E. coli. Therefore, beta-lactam 
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The spread of genes coding for extended-spectrum 
beta-lactamases (ESBLs) among Enterobacteriaceae 
is alarming globally and is of significant public health 
concern (NORM, 2010). It is thought that over one 
billion people are colonized with ESBL-producing 
Enterobacteriaceae intestinally. The major agents of 
the propagation of these strains are misuse and over 
usage of antibiotics in humans and animals and 
circulation of antibiotic residues and ESBL in the 
environment (Zhang et al., 2015; Canton et al., 2012; 
Tenaillon et al., 2010). Patients with infections 
caused by ESBL are known to suffer from increased 
incidence of diseases and death rate compared to 
patients with infections caused by non-ESBL-
producing Enterobacteriaceae (Rottier et al., 2012).  
 
 Extended-spectrum beta-lactamase-producing 
Enterobacteriaceae can be disseminated in humans 
through contaminated food or water (Zhang et al., 
2015) and capable of inactivating extended-spectrum 
cephalosporin. They can be inhibited by extended 
spectrum β-lactamase inhibitors, such as clavulanic 
acid via plasmid-encoded or chromosomonally-
encoded β-lactamases. Water environments are 
considered as one of the major reservoirs for 
resistance genes (Zhang et al., 2015), and possibly 
play a significant role in transfer of drug-resistant 
genes between bacteria (Malakoff, 2002; Kummerer, 
2004).  
 
 Escherichia coli is the most widespread pathogenic 
organism among Enterobacteriaceae in human 
diseases and causes serious and common infections 
such as septicemia and urinary tract infection (UTI) 
(NORM, 2010). It is also the most commonly 
occurring ESBL-producing enterobacteriaceae, which 
are inhabitants of gastrointestinal tract and important 
pathogens in nosocomial and in the environment 
(Song et al., 2011; Tenaillon et al., 2010).  
 
To date in Nigeria, there are numerous studies on 
ESBL-producing Enterobacteriaceae from clinical 
isolates. However, information on ESBL-producing 
Enterobacteriaceae isolated from waters from rivers is 
very limited. The global occurrence of antibiotic 
resistance of E. coli in water is of increasing concern; 
this informed the need to assess the impact of 
pollution on Asa river segments and evaluate the 
effectiveness of augmentation of clavulanate with 
Cefotaxime, Ceftazidime, Aztreonam and Ceftriaxone 
in detecting ESBL production in the E. coli isolates. 
This study aimed at investigating the prevalence of 
genes coding for ESBL-production in E. coli isolated 
from Asa River in Ilorin, Nigeria. 
 
 MATERIALS AND METHODS 
 Study Area and Water Sampling: Water sampling 
was carried out at weekly intervals for a period of 8 
weeks on Asa River in Ilorin, Nigeria. The study was 
conducted on 5 different Asa River segments; 
Amilegbe road, Station road, Unity road, Offa-garage 
road and Asa dam. The samples were collected into 
pre-sterilized bottles kept on ice and transported 
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immediately to the laboratory for analyses within 2 
hours. 
 
 Isolation and Identification: Isolates were recovered 
from the water samples after incubation on Eosin 
Methylene Blue Agar and MacConkey Agar, for 18–
24 hours at 37°C. Presumptive characteristic E. coli 
isolates were identified and confirmed using IMViC 
tests while potential ESBL producers were identified 
based on manufacturers’ instructions (Oxoid Ltd, 
England).  
 
Double Disc Synergy Test / DDST: The double disc 
detection test was done by determining the synergy 
between a disc of amoxicillin-clavulanate (AMC30) 
and a 30-µg disc of each third-generation 
cephalosporin test antibiotic placed at a distance of 20 
mm from centre to centre on a Mueller-Hinton Agar 
(MHA) plate inoculated with the test isolate. Clear 
extension of the edge of the inhibition zone of 
cephalosporin toward the amoxicillin-clavulanate disc 
was interpreted as positive for ESBL production 
(Bradford et al., 1997) while no enhancement 
between any of the cephalosporins and the clavunate-
containing discs was regarded as negative.   
 
Plasmid Curing: The ESBL positive isolates were 
subjected to acridine orange (Merck) mediated 
plasmid elimination using the method of Stanisich 
and were also re-tested for ESBL production using 
DDST (Iroha et al., 2010). 
 
 Isolation of genomic DNA of ESBL E. Coli and 
Detection of resistance gene using PCR method: Pure 
cultures were grown overnight in Nutrient broth and 
genomic DNA was extracted using the Cetyl 
Trimethyl Ammonium Bromide (CTAB) extraction 
procedure (Devi et al., 2013).  
 
In order to detect genes encoding Ambler class A 
beta-lactamases (bla), standard PCR was performed 
with genomic DNA as a template. For amplification 
of genes encoding SHV beta-lactamases (blaSHV), 
primers SHV-F 
(5'GACAGTTACCAATGCTTAATCA3') and SHV-
R (5'TCGGGCCGCGTAGGCATGAT 3') were used 
(Mojtaba and Behnaz, 2012). Reaction conditions 
used were 94°C for 300 s, followed by 36 cycles of 
denaturation (94°C; 60 s), annealing (39.5°C; 30 s) 
and extension (72°C; 120 s), and a final extension at 
72°C for 240 s. 
 
For amplification of genes encoding TEM beta-
lactamases (blaTEM), primers TEM-F 
(5'ATAAAATTCTTGAAGACGAAA 3' ) and TEM-
R (5'GACAGTTACCAATGCTTAATCA3') were 
used with thermal cycling conditions of  94°C for 300 
s, followed by 36 cycles of denaturation (94°C; 60 s), 
annealing (42.9°C; 30s), extension (72°C; 120 s), and 
a final extension at 72°C for 240 s. In order to detect 
genes for CTX-M beta-lactamases (blaCTX-M), primers 
CTX-MU1  
(5'TTAATGATGACTCAGAGCATTC 3’) and CTX-
MU2 (5'GATACCTCGCTCCATTTATTG3') were 
used and the thermal cycling condition as described 
above except annealing (49.2°C; 30 s).  
 
The PCR product stained with ethidium bromide was 
electrophorese in a 1.7 % (w/v) agarose gel for 1hr at 
140V together with High Ranger 1kb and PCR Sizer 
100bp DNA ladder (NORGEN) and visualized under 
UV illumination. 
 
 RESULTS AND DISCUSSION 
Eighty- four isolated E. coli were selected for 
phenotypic testing while 58(69.04%) showed 
positivity for ESBL. Table 1 shows The Percentage 
Resistance Pattern of the Isolates on the Various Beta 
Lactam Antibiotic Discs.  
The results of the plasmid curing with acridine orange 
revealed that all the ESBL positive E. coli could not 
express the ESBL enzyme after their incubation with 
0.1 mg/ml acridine orange.  
 
Figure 1 shows 16 of the 58 ESBL positive isolates 
that were subjected to PCR for the presence of 
blaSHV, blaTEM and blaCTX-M genes. 11(68.7%) of 
these had at least one ESBL gene (either blaCTX-M 
or blaTEM, or both), 5(31.3%) isolates didn’t have 
any of the three ESBL genes, and blaSHV was not 
detected in any of the isolates (Figures 2-4). 
 
Escherichia coli is a known pathogenic organism that 
has caused severe nosocomial, urinary tract infection, 
blood borne disease and gastroenteritis which has led 
to severe morbidity and increased death rate. 
Following the wide consumption and constant abuse 
of the extended spectrum beta lactam agent, the 
outbreaks of infection caused by extended spectrum 
β-lactamase producing E. coli have been widely 
reported throughout the world (Branger et al.,1998). 
The production of ESBLs is a major threat to the use 
of new generation of cephalosporins (Putman et al., 
2000; Mendes et al., 2004). Long hospitalization, 
diabetes, age over 60 and antibiotic treatment have 
been reported previously as the risk factors to acquire 
infections with ESBL strains (Silva et al., 2006). 
 
The present results showed that, out of the 84 E. coli 
isolates screened for β- lactamase production using 
third-generation Cephalosporins (Cefotaxime, 
Ceftriaxone and Ceftazidime) and monobactam 
(Aztreonam); 58(69.04%) showed positivity for 
ESBL production.  Previous studies reported that, 
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primary antimicrobial susceptibility test of E. coli 
isolates observed high resistance to third-generation 
Cephalosporins such as Cefotaxime, Ceftriaxone and 
Ceftazidime. Some studies also show resistance to β-
lactam antibiotics (especially third-generation 
Cephalosporins) and non-β- lactam antibiotics, 
amongst which clinical isolates of gram-negative 
bacteria are increasing worldwide (Goossens, 2000; 
Andrew, 2001) and this correlates with the present 
research. 
 
In this study, Ceftriaxone detected 28.6% of the 
ESBL producers at a distance of 20 mm. This was 
followed by Cefotaxime at 26.2%, Ceftazidime at 
23.8% and Aztreonam at 21.4% in the presence of 
Amoxicillin- clavulanic acid. It was observed that this 
study is in contrast to the work of Babypadmini and 
Appalara, (2004).  
 
The effect of plasmid curing studies in this study 
shows that the plasmid resistant maker of positive 
ESBL isolates was eliminated which means that the 
ESBL genes of these isolates (E. coli) are plasmid-
mediated. The percentage of isolates expressing 
ESBL production is variable in relation to previous 
reports of ESBL occurrence  from Nigeria with 
respect to the chromosomal and extra-chromosomal 
location of the resistance determinants.  On the other 
hand, Enabulele and Uraih (2009) reported that, the 
resistance by gram negative wound isolates was 
plasmid-mediated. Hence this study correlates with 
the study of Enabulele and Uraih (2009).  
 
However, in a later study, Yah et al., (2007) and 
Iroha et al., (2009) reported their findings that the 
production of ESBL can be chromosomal or plasmid 
in origin. When these are considered in relation to 
this present finding they seem to be in contrary. The 
ESBLs can either be carried on chromosomes or 
plasmids and plasmid-mediated ESBLs can carry 
genes that have the ability to transfer a replica of 
themselves to other bacteria. The transferable 
plasmids also code for resistant determinants to other 
antimicrobial agents, hence, multidrug resistance is 
anticipated to be commonest among ESBL- 
producing organisms. ESBLs that are chromosomal 
in origin cannot easily be transferred from organism 
to organism (Iroha et al., 2009). 
The most ESBLs in this study were CTX-type and 
TEM-type enzymes while failed to detect SHV-type 
in isolated E. coli. 68.8% of these had at least one 
ESBL gene (either blaCTX-M or blaTEM, or both), 
5(31.3%) isolates didn’t have any of the three ESBL 
genes.  The results in this study showed prevalence of 
CTX-type and SHV-type to be 68.7% and 25.0% 
respectively.  
 
In a similar report, the most abundant ESBL gene 
was blaCTX-M, the second-most prevalent gene 
was blaTEM and the blaSHV gene was not found (Su- 
Ying et al., 2010).  It has also been reported by Iroha 
et al., (2009) that, blaSHV gene could not be found in 
any of their isolates. The above studies correlate with 
the present finding while Mojtaba and Behnaz, (2011) 
failed to detect CTX-M type ESBL in the isolated 
strains which is in contrary to this research. The 
variation in this study results compared with others 
about prevalence rate of ESBLs may be due to 
different reasons such as difference in type and 
volume of consumption of antibiotics and difference 
in time which the isolates were collected (Al-Agamy 
et al., 2009). 
 
In epidemiological studies, the blaCTX-M gene has 
been widespread in clinical settings globally (Coque 
et al., 2008), but it has seldom been identified in 
environmental isolates.  Recently, Reinthaler et al. 
reported that the blaCTX-M gene was dominant in 
ESBL-producing bacteria isolated from Austrian 
sewage sludge, with the blaTEM gene as the second-
most prevalent type (Reinthaler et al., 2010). The 
present research was in concordance with the above 
study, but the latter data indicated that the CTX-M-
type ESBL- gene had already been prevalent in a 
river sediment environment. 
 
The blaCTX-M group is unique among ESBL genes. 
CTX-M was initially identified in 1989 and its 
pandemic (CTX-M) has changed the prevalence of 
ESBLs, and it has rapidly become the dominant 
ESBL worldwide (Canton and Coque, 2006). 
Previous reports suggest that the CTX-Ms had several 
different environmental origins, in contrast to TEM 
and SHV, with single ancestors (Barlow et al., 2008). 
CTX-M not only is associated with nosocomial 
outbreaks but is also mostly found in community-
acquired infections. The high degree of diversity 
of blaCTX-M genes in this present study, in the river 
could have two potential origins: the hospital effluent 
or naturally occurring strains. This result indicates 
that novel blaCTX-M genes could be identified from the 
environment and that the river environment could be 
a potential reservoir of novel ESBL genes that may 
pose a potential risk to public health. 
 
Table 1: The Percentage Resistance Pattern of the 
Isolates on the Various Beta Lactam Antibiotic Discs 
Antibiotic disc Inhibition zone No of isolates (%) 
Ceftriaxone ≤ 25mm 24 (28.60) 
Cefotaxime ≤ 27mm 22 (26.20) 
Ceftazidime ≤ 22mm 20 (23.80) 
Aztreonam ≤ 27mm 18 (21.40) 
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Fig 1: E.coli genomic DNA.M:1kb DNA marker; 
NC: negative control; Lanes 1-16: E. coli isolates 
genomic DNA template. 
 
 
Fig 2: blaCTX-M gene PCR amplicon. M: 1kb DNA 
marker; NC: negative control; lanes 1-16: E. coli 
isolates positive for the blaCTX-M gene. 
 
 
Fig 3: blaSHV gene PCR amplicon. M: 100 bp DNA 
marker; NC: negative control; lanes 1-16: E. coli 
isolates negative for the blaSHVgene. 
 
 
Fig 4: blaTEM gene PCR amplicon. M: 1kb DNA 
marker;  
NC: negative control; lanes 1-16: E. coli isolates 
positive for the blaTEM gene. 
  
Conclusion: There is apparently high prevalence of 
ESBL producing strains of E. coli in present study 
environment and the enzyme genes are plasmid 
mediated. The high prevalence of E. coli that showed 
resistance to Beta lactam antibiotics in the studied 
river in Kwara State call for a serious concern as this 
river serve as a source of livelihood for the people 
living in the environment. The outcome of this study 
has demonstrated the palpable presence of ESBL 
producing bacteria strains from community within 
Ilorin metropolis to the best of our knowledge. This 
kind of study remains relevant towards providing 
adequate baseline for the future projection and 
effective management of infectious diseases caused 
by the ESBL producing bacteria strains.  
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